1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
Alpha Healthcare Acquisition Corp. III

Alpha Healthcare Acquisition Corp. III

ALPAU
Alpha Healthcare Acquisition Corp. IIIUS flagNASDAQ Capital Market
9.75
USD
+0.31
- -
157.30MMarket Cap
Alpha Healthcare Acquisition Corp. III
ALPAU
(NASDAQ Capital Market)

Recent

price

9.75

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
Harvard Ave Acquisition Corporation Class A Ordinary Share (HAVA)
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (SLACW)
dMY Squared Technology Group, Inc. (DMYY)
Bellevue Life Sciences Acquisition Corp. (BLAC)
TZP Strategies Acquisition Corp. (TZPSW)
VectoIQ Acquisition Corp. II (VTIQU)
Business
Alpha Healthcare Acquisition Corp. III (ALPAU) operates as a blank check company, or special purpose acquisition company (SPAC), focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, primarily in the healthcare sector; it conducts no significant operations prior to completing such a transaction. Incorporated in 2021 and headquartered in New York, New York, the company targets healthcare entities in the United States. In July 2023, Alpha Healthcare Acquisition Corp. III completed a reverse merger with Carmell Therapeutics Corporation, a Phase 2 stage regenerative medicine platform company developing allogeneic plasma-based biomaterials for soft tissue repair, aesthetics, and orthopedic indications, resulting in the combined entity trading as Carmell Therapeutics Corporation (Nasdaq: CTCX); the transaction yielded approximately $29.4 million in gross proceeds from the trust after redemptions. Prior to the merger closing on July 14, 2023, the company raised $150 million through its initial public offering of 15 million units in July 2021 and entered a definitive business combination agreement with Carmell in January 2023, approved by stockholders in July 2023; it also signed a non-binding letter of intent in May 2023 for a potential follow-on acquisition of a commercial-stage regenerative medicine company, conditioned on the Carmell deal. The SPAC, led by Chairman and CEO Rajiv Shukla, maintains its focus on healthcare investments without current substantive products or services beyond pursuing de-SPAC transactions.